Research graph
References from Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery. Local targets link to admitted publications; unresolved targets remain external evidence.
Polymer-based oral peptide nanomedicines
10.4155/tde.12.40 · 2012 · External reference
Noninvasive routes of proteins and peptides drug delivery
2011 · External reference
10.5936/csbj.201209002
10.5936/csbj.201209002 · External reference
What is the future of noninvasive routes for protein- and peptide-based drugs?
10.4155/tde-2016-0031 · 2016 · External reference
Unresolved reference
2019 · External reference
Unresolved reference
External reference
10.4155/tde.14.111
10.4155/tde.14.111 · External reference
10.1002/jps.22054
10.1002/jps.22054 · External reference
Nanotechnology based approaches for anti-diabetic drugs delivery
10.1016/j.diabres.2017.11.018 · 2018 · External reference
Nasal drug delivery
10.1007/s13346-012-0111-1 · 2013 · External reference
10.1513/pats.200409-049ta
10.1513/pats.200409-049ta · External reference
Unresolved reference
2018 · External reference
10.1016/j.addr.2018.12.006
10.1016/j.addr.2018.12.006 · External reference
10.1016/j.addr.2018.01.008
10.1016/j.addr.2018.01.008 · External reference
Key factors influencing ADME properties of therapeutic proteins: a need for ADME characterization in drug discovery and development
10.1080/19420862.2015.1115937 · 2016 · External reference
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
10.1016/j.jsps.2014.06.004 · 2016 · External reference
10.1016/b978-0-12-384935-9.10005-7
10.1016/b978-0-12-384935-9.10005-7 · 2011 · External reference
Nanocarriers for pulmonary administration of peptides and therapeutic proteins
10.2217/nnm.10.143 · 2011 · External reference
10.1016/j.ijpharm.2013.02.030
10.1016/j.ijpharm.2013.02.030 · External reference
10.1016/s1773-2247(13)50055-4
10.1016/s1773-2247(13)50055-4 · External reference
10.1016/j.addr.2008.11.002
10.1016/j.addr.2008.11.002 · External reference
Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery
10.4155/tde.15.75 · 2015 · External reference
10.1016/j.addr.2016.02.004
10.1016/j.addr.2016.02.004 · External reference
Casein-based hydrogel carrying insulin: preparation, invitro evaluation and invivo assessment
2018 · External reference
Hydrogels for oral delivery of therapeutic proteins
10.1517/14712598.4.6.881 · 2004 · External reference
As a review on hydrogels as drug delivery in the pharmaceutical field
2012 · External reference
Complexation hydrogels as oral delivery vehicles of therapeutic antibodies: an invitro and exvivo evaluation of antibody stability and bioactivity
10.1021/acs.iecr.5b01193 · 2015 · External reference
Complexation hydrogels as potential carriers in oral vaccine delivery systems
10.1016/j.ejpb.2016.11.029 · 2017 · External reference
pH-responsivealginate-based hydrogels for protein delivery
10.1016/j.molliq.2018.04.002 · 2018 · External reference
Encapsulation of bovine serum albumin within novel xanthan gum based hydrogel for protein delivery
10.1016/j.msec.2018.10.040 · 2019 · External reference
Biodegradable polymeric nanoparticles based drug delivery systems
10.1016/j.colsurfb.2009.09.001 · 2010 · External reference
Fc-modifiedexenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice
10.1038/s41598-018-19170-y · 2018 · External reference
Oral insulin delivery by self-assembled chitosan nanoparticles: invitro and invivo studies in diabetic animal model
10.1016/j.msec.2012.09.001 · 2013 · External reference
Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update
10.1007/s40005-017-0372-2 · 2018 · External reference
Potential of different salt forming agents on the formation of chitosan nanoparticles as carriers for protein drug delivery systems
10.1007/s40005-017-0369-x · 2019 · External reference
Insulin-loaded nanoparticles based on N-trimethyl chitosan: invitro (Caco-2 model) and exvivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties
10.1208/s12249-010-9390-3 · 2010 · External reference
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport
10.1016/j.biomaterials.2011.10.075 · 2012 · External reference
Synthesis and invitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems
10.1166/jbn.2017.2407 · 2017 · External reference
A pH-sensitive nanosystem based on carboxymethyl chitosan for tumor-targeted delivery of daunorubicin
10.1166/jbn.2016.2278 · 2016 · External reference
Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics
10.1016/j.biomaterials.2010.07.111 · 2010 · External reference
Mesalamine-loaded alginate microspheres filled in enteric coated HPMC capsules for local treatment of ulcerative colitis: invitro and invivo characterization
10.1007/s40005-017-0304-1 · 2018 · External reference
pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery
10.1016/j.ijbiomac.2014.08.040 · 2015 · External reference
A review of biodegradable polymeric systems for oral insulin delivery
2016 · External reference
PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems
10.1007/s40005-019-00442-2 · 2019 · External reference
Preparation, characterization and invivo evaluation of pH-sensitive oral insulin-loaded poly (lactic-co-glycolicacid) nanoparticles
10.1111/j.1463-1326.2011.01546.x · 2012 · External reference
Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration
10.1016/j.ejps.2012.01.002 · 2012 · External reference
Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery
10.1007/s11051-012-1219-4 · 2012 · External reference
Pluronic P85/poly (lactic acid) vesicles as novel carrier for oral insulin delivery
10.1016/j.colsurfb.2013.06.019 · 2013 · External reference
10.1126/scitranslmed.3007049
10.1126/scitranslmed.3007049 · External reference
Redox sensitive shell and core crosslinked hyaluronic acid nanocarriers for tumor-targeted drug delivery
10.1166/jbn.2016.2279 · 2016 · External reference
Redox-sensitive smart nanosystems for drug and gene delivery
10.2174/1385272820666160510154557 · 2016 · External reference
Effective gene delivery using stimulus-responsive catiomer designed with redox-sensitive disulfide and acid-labile imine linkers
10.1021/bm2017355 · 2012 · External reference
Nutraceutical emulsion containing valproic acid (NE-VPA): a drug delivery system for reversion of seizures in zebrafish larvae epilepsy model
10.1007/s40005-017-0316-x · 2017 · External reference
Pharmacokinetics of curcumin-loadedPLGA and PLGA–PEG blend nanoparticles after oral administration in rats
10.1016/j.colsurfb.2012.06.024 · 2013 · External reference
Nano-sizedwater-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compound
10.1016/j.ejpb.2009.09.004 · 2010 · External reference
Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery
10.1016/j.ejps.2010.01.006 · 2010 · External reference
Protein-loaded emulsion electrospun fibers optimized for bioactivity retention and pH-controlled release for peroral delivery of biologic therapeutics
10.1016/j.ijpharm.2017.09.043 · 2017 · External reference
Enhancement of invitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDS
10.1007/s40005-017-0308-x · 2018 · External reference
Self microemulsifying particles of loratadine for improved oral bioavailability: preparation, characterization and invivo evaluation
10.1007/s40005-017-0344-6 · 2018 · External reference
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability
10.1016/j.drudis.2010.08.007 · 2010 · External reference
Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability
10.1016/j.ijpharm.2011.02.047 · 2011 · External reference
Combining two technologies: Multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration
10.1016/j.ijbiomac.2013.08.002 · 2013 · External reference
10.1016/j.reactfunctpolym.2010.10.002
10.1016/j.reactfunctpolym.2010.10.002 · External reference
Drug targeting to the colon with lectins and neoglycoconjugates
10.1016/j.addr.2003.10.017 · 2004 · External reference
In vitro and invivo evaluation of WGA–carbopol modified liposomes as carriers for oral peptide delivery
10.1016/j.ejpb.2010.12.008 · 2011 · External reference
Investigation of archaeosomes as carriers for oral delivery of peptides
10.1016/j.bbrc.2010.03.041 · 2010 · External reference
Archaeosomes with encapsulated antigens for oral vaccine delivery
10.1016/j.vaccine.2011.05.015 · 2011 · External reference
Microneedles for drug delivery via the gastrointestinal tract
10.1002/jps.24182 · 2015 · External reference
10.1002/btm2.10015
10.1002/btm2.10015 · External reference
10.1039/c8nr04073g
10.1039/c8nr04073g · External reference
Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases
10.1208/s12248-015-9719-7 · 2015 · External reference
Microemulsion for nasal delivery of Asenapine maleate in treatment of schizophrenia: formulation considerations
10.1007/s40005-017-0318-8 · 2018 · External reference
10.1016/j.biomaterials.2012.08.070
10.1016/j.biomaterials.2012.08.070 · External reference
10.1016/b978-0-12-814031-4.00021-0
10.1016/b978-0-12-814031-4.00021-0 · 2019 · External reference
New strategies to improve the intranasal absorption of insulin
10.1016/j.drudis.2010.03.011 · 2010 · External reference
10.1007/978-1-4614-9524-6_8
10.1007/978-1-4614-9524-6_8 · 2014 · External reference
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin
10.1002/jbm.b.31161 · 2009 · External reference
Antigen−adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
10.1021/mp100210g · 2010 · External reference
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake
10.1002/jps.21674 · 2009 · External reference
Nanostructured polysaccharide-based carriers for antimicrobial peptide delivery
10.1007/s40005-016-0289-1 · 2017 · External reference
10.1016/j.jconrel.2015.11.009
10.1016/j.jconrel.2015.11.009 · External reference
Design and efficacy of nanogels formulations for intranasal administration
10.3390/molecules23061241 · 2018 · External reference
Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease
10.1016/j.biomaterials.2015.11.057 · 2016 · External reference
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
10.1038/nmat2819 · 2010 · External reference
10.1016/j.biochi.2016.07.003
10.1016/j.biochi.2016.07.003 · External reference
The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA
10.1016/j.ejps.2013.07.006 · 2013 · External reference
Development and characterization of gels and liposomes containing ovalbumin for nasal delivery
10.1016/j.jddst.2017.12.006 · 2018 · External reference
Potential of nanoparticulate carriers for improved drug delivery via skin
2018 · External reference
Application of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)
10.1007/s40005-016-0300-x · 2017 · External reference
Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application
10.1016/j.xphs.2016.10.001 · 2017 · External reference
Transdermal patches of chitosan nanoparticles for insulin delivery
2015 · External reference
Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loadedPLGA nanoparticles elicits protective Tcell-mediated immunity to an intracellular bacterium
10.1016/j.jconrel.2017.09.017 · 2017 · External reference
Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery
10.1016/j.ejpb.2018.05.031 · 2018 · External reference
Promotion of the transdermal delivery of protein drugs by N-trimethyl chitosan nanoparticles combined with polypropylene electret
10.2147/ijn.s109552 · 2016 · External reference
10.1016/j.actbio.2018.09.013
10.1016/j.actbio.2018.09.013 · External reference
Unresolved reference
2012 · External reference
Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications
10.1016/j.jconrel.2017.11.049 · 2018 · External reference
Development and invitro evaluation of a nanoemulsion for transcutaneous delivery
10.3109/03639045.2012.763137 · 2014 · External reference
Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection
10.1016/j.jdermsci.2017.06.012 · 2017 · External reference
Development and evaluation of microemulsions for transdermal delivery of insulin
10.5402/2011/780150 · 2011 · External reference
10.1002/biot.201600081
10.1002/biot.201600081 · External reference
Ionic liquid-mediated transcutaneous protein delivery with solid-in-oil nanodispersions
10.1039/c5md00378d · 2015 · External reference
In vitro and computational studies of transdermal perfusion of nanoformulations containing a large molecular weight protein
10.1016/j.colsurfb.2013.02.032 · 2013 · External reference
Transdermal delivery of insulin using a solid-in-oil nanodispersion enhanced by arginine-rich peptides
10.1039/c2md20059g · 2012 · External reference
Enhanced topical delivery of fish scale collagen employing negatively surface-modified nanoliposome
10.1007/s40005-017-0303-2 · 2018 · External reference
Liposomes in cosmeceutics
10.1517/17425247.2012.666968 · 2012 · External reference
10.1016/j.ijpharm.2018.11.032
10.1016/j.ijpharm.2018.11.032 · External reference
Transdermal delivery from liposomal formulations – evolution of the technology over the last three decades
10.1016/j.jconrel.2016.09.008 · 2016 · External reference
Transferosome: a recent approach for transdermal drug delivery
10.22270/jddt.v8i5-s.1981 · 2018 · External reference
Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery
10.1016/j.jsps.2012.02.001 · 2012 · External reference
Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P.falciparum surface antigen, MSP-119
10.1016/j.vaccine.2015.06.054 · 2015 · External reference
Nano-formulations for transdermal drug delivery: a review
10.1016/j.cclet.2018.10.037 · 2018 · External reference
Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes
10.2147/ijn.s46748 · 2013 · External reference
Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant
10.2147/ijn.s132456 · 2017 · External reference
Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant
10.1016/j.ijpharm.2013.02.006 · 2013 · External reference
Novel bilayer dissolving microneedle arrays with concentrated PLGAnano-microparticles for targeted intradermal delivery: proof of concept
10.1016/j.jconrel.2017.10.005 · 2017 · External reference
10.4155/tde.13.104
10.4155/tde.13.104 · External reference
10.1517/17425247.2013.797405
10.1517/17425247.2013.797405 · External reference
10.1016/j.biopha.2018.10.078
10.1016/j.biopha.2018.10.078 · External reference
10.1016/j.jconrel.2012.01.042
10.1016/j.jconrel.2012.01.042 · External reference
10.1016/j.addr.2018.01.015
10.1016/j.addr.2018.01.015 · External reference
Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha
10.1088/1758-5090/8/1/015006 · 2016 · External reference
Dissolving microneedle arrays for transdermal delivery of amphiphilic vaccines
2017 · External reference
IgG-loadedhyaluronan-based dissolving microneedles for intradermal protein delivery
10.1016/j.jconrel.2015.10.002 · 2015 · External reference
Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin
10.1016/j.actbio.2015.06.021 · 2015 · External reference
10.1016/j.jconrel.2017.03.041
10.1016/j.jconrel.2017.03.041 · External reference
10.1038/nmat3776
10.1038/nmat3776 · External reference
10.1021/acsnano.7b08152
10.1021/acsnano.7b08152 · External reference
10.1208/s12249-011-9601-6
10.1208/s12249-011-9601-6 · External reference
Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats
10.1007/s11095-007-9308-2 · 2007 · External reference
10.1016/j.ultras.2013.07.007
10.1016/j.ultras.2013.07.007 · External reference
10.3109/10717544.2014.951102
10.3109/10717544.2014.951102 · External reference
10.1016/b978-0-12-384964-9.00012-8
10.1016/b978-0-12-384964-9.00012-8 · 2011 · External reference
Electroporation parameters for successful transdermal delivery of insulin
10.1097/mjt.0000000000000198 · 2016 · External reference
Electronically facilitated transdermal delivery of human parathyroid hormone (1–34)
10.1016/s0378-5173(03)00337-5 · 2003 · External reference
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
2019 · External reference
Pulmonary delivery of proteins using nanocomposite microcarriers
10.1002/jps.24681 · 2015 · External reference
Pulmonary drug delivery strategies: a concise, systematic review
10.4103/0970-2113.92361 · 2012 · External reference
Polymeric nanoparticles for pulmonary protein and DNA delivery
10.1016/j.actbio.2014.01.033 · 2014 · External reference
10.1186/rr58 · 2001 · Admitted local publication
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles
10.1007/s40005-019-00439-x · 2019 · External reference
Microencapsulated SLN: an innovative strategy for pulmonary protein delivery
10.1016/j.ijpharm.2016.11.037 · 2017 · External reference
Ocular delivery of macromolecules
10.1016/j.jconrel.2014.06.043 · 2014 · External reference
Protein aggregation: a rescue by chaperones
10.1038/nchembio.2006 · 2016 · External reference
10.1021/cr050247k
10.1021/cr050247k · External reference
Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
10.1016/j.actbio.2016.05.011 · 2016 · External reference
Composite nanoformulation therapeutics for long-term ocular delivery of macromolecules
10.1021/acs.molpharmaceut.5b00828 · 2016 · External reference
10.1016/j.jconrel.2017.01.012
10.1016/j.jconrel.2017.01.012 · External reference
10.1016/j.jconrel.2008.12.018
10.1016/j.jconrel.2008.12.018 · External reference
Anti-Flt1peptide–hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy
10.1016/j.biomaterials.2011.01.003 · 2011 · External reference
10.3390/molecules21081002
10.3390/molecules21081002 · External reference
Dendrimers for ocular drug delivery
10.1139/cjc-2017-0193 · 2017 · External reference
Dendrimeric systems and their applications in ocular drug delivery
10.1155/2013/732340 · 2013 · External reference
Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs
10.1016/j.nano.2011.08.018 · 2012 · External reference
Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration
10.1021/nn301873v · 2012 · External reference
Dendrimer and dendrimer–conjugate protein complexes and protein coronas
10.1139/cjc-2017-0198 · 2017 · External reference
Dexamethasone nanowafer as an effective therapy for dry eye disease
10.1016/j.jconrel.2015.07.007 · 2015 · External reference
10.1021/nn506599f
10.1021/nn506599f · External reference
Therapeutic contact lenses with polymeric vehicles for ocular drug delivery: a review
10.3390/ma11071125 · 2018 · External reference
Targeting therapy of choroidal neovascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure
10.1007/s11596-010-0661-8 · 2010 · External reference
Designing lipid nanoparticles for topical ocular drug delivery
10.1016/j.ijpharm.2017.09.017 · 2017 · External reference
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving invivo ocular bioavailability
10.1002/jps.23251 · 2012 · External reference
Gene delivery in the cornea: invitro & exvivo evaluation of solid lipid nanoparticle-basedvectors
10.2217/nnm-2018-0112 · 2018 · External reference
Nanotechnology in ocular drug delivery
10.1016/j.drudis.2007.10.021 · 2008 · External reference
Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium
10.1007/s40005-017-0365-1 · 2018 · External reference
Nanocarriers in improved heparin delivery: recent updates
10.2174/1381612821666150821112808 · 2015 · External reference
10.1016/j.ijbiomac.2018.09.044
10.1016/j.ijbiomac.2018.09.044 · External reference
Methylcellulose and polyacrylate binary hydrogels used as rectal suppository to prevent type I diabetes
10.1016/j.colsurfb.2018.08.021 · 2018 · External reference
10.1016/j.mtchem.2018.09.001 · Admitted local publication
Targeting delivery of anti-TNFα oligonucleotide into activated colonic macrophages protects against experimental colitis
10.1136/gut.2009.184556 · 2010 · External reference
10.1016/j.ejpb.2018.06.029
10.1016/j.ejpb.2018.06.029 · External reference
10.1002/jbm.a.36305
10.1002/jbm.a.36305 · External reference
Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: towards a novel treatment strategy in colitis
10.1016/j.lfs.2016.11.015 · 2017 · External reference
The application of carbon nanotubes in target drug delivery systems for cancer therapies
10.1186/1556-276x-6-555 · 2011 · External reference
Physicochemical characterization and cytotoxicity of chitosan-modified single walled carbon nanotubes as drug carriers
10.1007/s40005-018-0384-6 · 2019 · External reference
Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles
10.1016/j.intimp.2016.08.007 · 2016 · External reference
Computational modeling for formulation design
10.1016/j.drudis.2018.11.018 · 2019 · External reference
10.1016/j.nano.2011.05.006
10.1016/j.nano.2011.05.006 · External reference
10.1016/j.bbamem.2016.02.028
10.1016/j.bbamem.2016.02.028 · External reference
Identification of protein-excipient interaction hotspots using computational approaches
10.3390/ijms17060853 · 2016 · External reference
10.4155/tde-2017-0024
10.4155/tde-2017-0024 · External reference
10.1016/j.tibtech.2009.07.009
10.1016/j.tibtech.2009.07.009 · External reference
Advanced formulations for intranasal delivery of biologics
10.1016/j.ijpharm.2018.10.029 · 2018 · External reference
Effect of regulatory requirement for patient-specific prescriptions for off-label medications on the use of intravitreal bevacizumab
10.1001/jamaophthalmol.2015.4331 · 2016 · External reference
